News About: R&D
Domestic drug makers skimping on R&D investment
Despite their relatively large assets, the nation’s 34 Korean pharmaceutical companies spend considerably less on research and development (R&D) than promotional expenses, industry data showed recently.
According t...
CellBiotech's drug for atopic therapy to complete clinical studies.
CellBiotech announced on Sept. 14 that a domestic clinical study on the new drug developed from a lactobacillus bacteria, a combined ATP lactobacillus, for the treatment of atopic skin diseases was successfully comple...
Korea scientist found carcinogenic mechanism by FH defect
Prof. Chung Yeong-jin of Busan National Univ. College of Pharmacy reported his study on the August edition of a world medical journal "Cancer Cell" about a molecular level of the carcinogenic mechanism by an FH (fumar...
LG Life Science to develop vaccines for bovine mastitis
LG Life Science has succeeded in developing a vaccine for the bovine mastitis through a gene recombinant technology first in Korea.
LG Life Science developed the bovine mastitis vaccine for the milk cows by using a...
A Korean scientist discovered a new anti-septic drug.
NG Chem announced that an excellent anti-septic compound was discovered from antlers in a joint research with Prof. Kim Sang-hee of the former medical specialist at Seoul Ahsan hospital.
The company developed a mas...
GeneMatrix to develop a new gene diagnostic technology
A Korean scientist developed a new gene diagnostic technology.
GeneMatrix, a bio venture company in Korea, announced that a lot of gene mutation found in viral genes or human genome can be detected collectively, wh...
Kukje to develop a new oral Carbapenem antibiotic
Kukje pharmaceutical company announced that they jointly discovered two carbapenem antibiotics, KR-34008 and KR-34020 with Korea Institute of Chemical Technology (KRICT) and put them into the preclinical studies, whic...
New drug screening technologies transferring to overseas
A screening technology for the discovery of new drugs has been transferred to the overseas.
The Korea Health Industry Development Institute (KHIDI) announced that the screening system technologies for the developme...
Jeil to study stem cells for Parkinson disease
Dr. Cho Myeong-soo and associates of Jeil Central Research Lab. announced to initiate a stem cell research for the treatment of Parkinson disease based on their research experiences in the nerve cell division.
Park...
Sodium Thiosulfate Effectively Reduces Toxicity and Improves Survival Rate
The clinical study conducted by a team of researchers from the United States shows that sodium thiosulfate, a chemoprotective agent, effectively reduced toxicity and thus enabled dose escalation of antineoplastic cisp...
